Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prohibitin 1 pseudogene 16 (PHB1P16) would refer to a non-functional genetic element homologous to the prohibitin 1 (*PHB1*) gene, presumed to lack coding potential for protein. While some prohibitin pseudogenes, such as PHBP1, have regulatory functions (including mRNA duplex formation that stabilizes parent gene transcripts and potential roles in carcinogenesis), PHB1P16 itself is not documented as an active biomolecule, therapeutic target, or established biomarker. The *PHB1* gene encodes a multifunctional protein involved in mitochondrial function, transcriptional regulation, cell signaling, and disease processes (including cancer and inflammation), but there is no evidence for PHB1P16's direct involvement in these functions[1][3][4][5]. If you are seeking information on the functional, protein-coding *PHB1* gene or on documented prohibitin pseudogenes (like PHBP1 or PHBP19), please clarify, as these have established biological and disease relevance[1][3][4][5].
None directly for drugs; some pseudogenes can regulate parent genes via mRNA duplex formation[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prohibitin 1 pseudogene 16 (PHB1P16).